Whats new
Whats new.
CLSA - Checking-off key points; Positive survival data in triple combo incrementally derisk TACTI-004; Maintain Outperform, A$0.95 PT (Analyst: Andrew Paine)
November 14th 2024
For a copy of this research report please contact your CLSA advisor